Trial intelligence / Profile preview

Neutrino Therapy for Chronic HCV Genotype 1b

NCT02480686Phase 4Completed

Sponsor
Humanity & Health Research Centre
Start
Jan 2015
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sofosbuvir in hepatitis C (HCV), sponsored by Humanity & Health Research Centre. Started Jan 2015; status: completed.

02

Drugs

sofosbuvir
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT02480686.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02480686.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call